Vaccine hesitancy is an economic and health disaster
In his latest opinion piece for the Australian Financial Review, Sam Lovick places some of the blame for COVID-19 vaccine hesitancy in […]
Category: COVID-19
Are reduced adverse events worth the costs of delays in achieving COVID-19 herd immunity?
In the Australian Financial Review, 13th April 2021, Sam Lovick asks whether possible delays in COVID-19 vaccination resulting from restricted use of […]
Genetic testing to help protect workers in the COVID-19 pandemic
Genetic Technologies is developing a Polygenic Risk Score (PRS) test for COVID-19 which may enable an assessment of risk of an individual […]
COVID-19 roadmap to recovery
Published in the Australian Financial Review, Dr Brian McNamee AO (writing in his personal capacity) and Sam Lovick question whether Premier Andrews’ […]
Should we follow a suppression or an elimination strategy for COVID-19
In a recent article published in the Financial Review, Sam Lovick reiterates that suppression is the best way to balance the health […]
Will there be a second COVID-19 wave in Australia?
In a recent article published in the Financial Review, Sam Lovick reviews whether there will be a second wave in Australia. He […]
COVID-19. Where to from here?
In a recent article published in the Financial Review, Sam Lovick reviews whether the costs and benefits of Australia’s current approach to the […]
A managed spread of COVID-19 may be best
In a recent article published in the Financial Review, Sam Lovick reviews whether the costs and benefits of Australia’s current approach to […]
Lowering the cost of COVID-19 pandemic interventions
In a recent article published in the Financial Review, Sam Lovick estimates how much Australia is likely to spend for each life […]